Nonviral, cationic lipid-mediated delivery of mRNA

Methods in Molecular Biology

Volumn 969, Issue , 2013, Pages 73-88

  Hecker, James G ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

CHO; DNA; Gene delivery; Lipid mediated; Molecular therapy; NIH3T3; Nonviral; Post mitotic; Primary neurons; RNA; SiRNA; Transfection; Transient

Indexed keywords

BIOTIN; CATION; DIAMINOBENZIDINE; GREEN FLUORESCENT PROTEIN; HEMOGLOBIN BETA CHAIN; LIPID; LIPOCORTIN 5; LIPOPLEX; LUCIFERASE; MESSENGER RNA; NUCLEIC ACID; DNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL LINE; CONJUGATION; CONTROLLED STUDY; CYTOTOXICITY; DNA TEMPLATE; DNA TRANSFECTION; FEMALE; FETUS; FLOW CYTOMETRY; GENE TARGETING; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; NERVE CELL; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PLASMID; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REPORTER GENE; RNA SYNTHESIS; TISSUE PREPARATION; TRANSIENT EXPRESSION; CHEMISTRY; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; METHODOLOGY; PROTEIN SYNTHESIS; SYNTHESIS; TIME;

DNA; GENE EXPRESSION; LIPIDS; PROTEIN BIOSYNTHESIS; RNA, MESSENGER; TIME FACTORS; TRANSFECTION;

MLCS; MLOWN;

EID: 84878665056     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-260-5_5     Document Type: Article

References (49)

1. Flotte TR (2007) Gene therapy: the first two decades and the current state-of-The-art. J Cell Physiology 213:301-305
2. Li SD, Huang L (2006) Gene therapy progress and prospects: non-viral gene therapy by systemic delivery. Gene Ther 13:1313-1319
3. Gao X, Kim KS, Liu D (2007) Nonviral gene delivery: what we know and what is next. AAPS J 9:E92-E104
4. Felgner PL, Tsai YJ, Sukhu L, Wheeler CJ, Manthorpe M, Marshall J, Cheng SH (1995) Improved cationic lipid formulations for in vivo gene therapy. Ann NY Acad Sci 772:1126-1139
5. Luo D, Saltzman WM (2000) Synthetic DNA delivery systems. Nat Biotechnol 18:33-37
6. Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, Northrop JP, Ringold GM, Danielsen M (1987) Lipofection: a highly ef ficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci 84:7413-7417
7. Byk G, Scherman D (2000) Genetic chemistry: tools for gene therapy coming from unexpected directions. Drug Dev Res 50:566-572
8. Niedzinski EJ, Fujii SK, Lizarzaburu ME, Hecker JG, Nantz MH (2002) A versatile linker for non-toxic polyamine-mediated DNA transfection. Mol Ther 6:279-286
9. Nantz MH, Dicus CW, Hilliard B, Yellayi S, Scarfo KA, Zou S, Hecker JG (2010) Unsymmetrical hydrophobic domains improve in vivo transfection ef ficiency. Mol Pharm 7:786-794
10. Bally MB, Harvie P, Wong FM, Kong S, Wasan EK, Reimer DL (1999) Biological barriers to cellular delivery of lipid-based DNA carriers. Adv Drug Deliv Rev 38:291-315
11. Girao da Cruz MT, Simoes S, Pires PPC, Nir S, Pedrosa de Lima MC (2001) Kinetic analysis of the initial steps involved in lipoplex-cell interactions: effect of various factors that in fl uence transfection activity. Biochim Biophys Acta 1510:136-151
12. Mortimer I, Tam P, MacLachlan I, Graham RW, Saravolac EG, Joshi PB (1999) Cationic lipid-mediated transfection of cells in culture requires mitotic activity. Gene Ther 6:403-411
13. Zabner J, Fasbender AJ, Moninger T, Poellinger KA, Welsh MJ (1995) Cellular and molecular barriers to gene transfer by a cationic lipid. J Biol Chem 270:18997-19007
14. Wangerek LA, Dahl HH, Senden TJ, Carlin JB, Jans DA, Dunstan DE, Ioannou PA, Williamson R, Forrest SM (2001) Atomic force microscopy imaging of DNA-cationic liposome complexes optimized for gene transfection into neuronal cells. J Gene Med 3:72-81
15. Zou S, Scarfo KA, Nantz MH, Hecker JG (2010) Lipid-mediated delivery of RNA is more ef ficient that DNA in non-dividing cells. Int J Pharm 389:232-240
16. Wilke M, Fortunati E, van den Broek M, Hoogeveen AT, Scholte BJ (1996) Ef ficacy of a peptide-based gene delivery system depends on mitotic activity. Gene Ther 3:1133-1142
17. Nicolau C, Sene C (1982) Liposome-mediated DNA transfer in eukaryotic cells. Dependence of the transfer ef ficiency upon the type of liposomes used and the host cell cycle stage. Biochim Biophys Acta 721:185-190
18. Mattaj IW, Englmeier L (1998) Nucleocytoplasmic transport: the soluble phase. Annu Rev Biochem 67:265-306
19. Wilson GL, Dean BS, Wang G, Dean DA (1995) Nuclear import of plasmid DNA in digitonin-permeabilized cells requires both cytoplasmic factors and speci fic DNA sequences. J Biol Chem 270:22025-22032
20. Malone RW, Felgner PL, Verma IM (1989) Cationic liposome-mediated RNA transfection. Proc Natl Acad Sci 86:6077-6081
21. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Felgner PL (1990) Direct gene transfer into mouse muscle in vivo. Science 247:1465-1468
22. Brisson B, Tseng W-C, Almonte C, Watkins S, Huang L (1999) Subcellular traf ficking of the cytoplasmic expression system. Hum Gene Ther 10:2601-2613
23. Anderson DM, Hall LL, Ayyalapu AR, Irion VR, Nantz MH, Hecker JG (2003) Stability of mRNA/cationic lipid lipoplexes in human and rat cerebrospinal fl uid: methods and evidence for nonviral mRNA gene delivery to the central nervous system. Hum Gene Ther 14:191-202
24. Felgner JH, Kumar R, Sridhar CN, Wheeler CJ, Tsai YJ, Border R, Ramsey P, Martin M, Felgner PL (1994) Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J Biol Chem 269:2550-2561
25. Sambrook D, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual. 1st, Cold Spring Harbor Lab, Cold Spring Harbor NY
26. Krieg PA, Melton DA (1984) Functional messenger RNAs are produced by SP6 in vitro transcription of cloned cDNAs. Nucleic Acids Res 12:7057-7070
27. Anderson DM, Hall LL, Ayyalapu A, Irion VR, Nantz MH, Hecker JG (2003) Stability of mRNA/cationic lipid lipoplexes in human and rat cerebrospinal fl uid: methods and evidence for non-viral mRNA gene delivery to the CNS. Hum Gene Ther 14:191-202
28. Hauck ES, Zou S, Scarfo KA, Nantz MH, Hecker JG (2008) Whole animal in vivo imaging after transient non-viral lipid-mediated gene transfer to the rat central nervous system. Mol Ther 16:1857-1864
29. Hecker JG, Hall LL, Irion VR (2001) Nonviral gene delivery to the lateral ventricles in rat brain: initial evidence for widespread distribution and expression in the central nervous system. Mol Ther 3:375-384
30. Balasubramaniam RP, Bennett MJ, Aberle AM, Malone JG, Nantz MH, Malone RW (1996) Structural and functional analysis of cationic transfection lipids: the hydrophobic domain. Gene Ther 3:163-172
31. Bennett MJ, Nantz MH, Balasubramaniam RP, Gruenert DC, Malone RW (1995) Cholesterol enhances cationic liposome-mediated DNA transfection on human respiratory epithelial cells. Biosci Rep 15:47-53
32. Bennett MJ, Aberle AM, Balasubramaniam RP, Malone JG, Nantz MH, Malone RW (1996) Considerations for the design of improved cationic amphiphile-based transfection reagents. J Liposome Res 6:545-565
33. McKinney JS, Willoughby KA, Liang S, Ellis EF (1996) Stretch-induced injury of cultured neuronal, glial, and endothelial cells. Stroke 27:934-940
34. Promega Corporation (2012) Transfast transfection reagent. Promega Corporation website, catalog number E2431
35. Corish P, Tyler-Smith C (1999) Attenuation of green fl uorescent protein half-life in mammalian cells. Protein Eng 12:1035-1040
36. University of Arizona (2008) Southwest animal imaging resource
37. Ignowski JM, Schaffer DV (2004) Kinetic analysis and modeling of fire fl y luciferase as a quantitative reporter gene in live mammalian cells. Biotechnol Bioeng 86:827-834
38. Allen MS, Wilgus JR, Chewning CS, Sayler GS, Simpson ML (2006) A destabilized bacterial luciferase for dynamic gene expression studies. Syst Synth Biol 1:3-9
39. Bartlett DW, Davis ME (2006) Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging. Nucleic Acids Res 34: 322-333
40. Hecker JG, Langer DJ, Marshall BE, Barnathan ES, Kariko K (1995) Feasibility studies of mRNA transfection for intermediate duration, perioperative modulation of CNS responses accessible via the cerebrospinal fl uid. Anesthesia & Analgesia AUA Abstracts 9999: 1-2
41. Hecker JG, Irion VR, Malone RW (1997) Self-limited gene expression in-vitro in neuronal cell cultures and in-vivo in rat brain using mRNA/cationic lipid complexes. Anesthesia Analgesia 84: S360
42. Hecker JG, Irion VR (1998) Advances in transient expression of neuroprotective intracellular proteins in-vivo in rat brain. AUA 45th Annual Meeting May 7-9
43. Hecker JG, Nantz MH (2008) Novel methods and models for rapid, widespread delivery of genetic materials to the CNS using non-viral, cationic lipid-mediated vectors. PCT/US2006/048093
44. Hecker JG, Irion VR (1998) Expression of protective intracellular proteins in-vivo in rat brain using mRNA/cationic lipid complexes. Am Soc Gene Ther 1st Mtg, May 28-31, 154A
45. Hecker JG, Irion VR (1998) Advances in selflimited gene expression of protective intracellular proteins in vivo in rat brain using mRNA/cationic lipid complexes. Anesthesia Analgesia 86: S346
46. Kariko K, Muramatsu H, Ludwig J, Weissman D (2012) Generating the optimal mRNA for therapy: HPLC puri fication eliminates immune activation and improves translation of nucleoside-modi fied, protein-encoding mRNA. Nucleic Acids Res 2011;39(21):e142
47. Kariko K, Muramatsu H, Welsh FA, Ludwig J, Kato H, Akira S, Weissman D (2008) Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol Ther 16:1833-1840
48. Kariko K, Megyeri K, Xiao Q, Barnathan ES (1994) Lipofectin-aided delivery of ribozyme targeted to human urokinase receptor mRNA. FEBS Lett 352:41-44
49. Kariko K, Keller JM, Harris VA, Langer DJ, Welsh FA (2001) In vivo protein expression from mRNA delivered into adult rat brain. J Neurosci Methods 105:77-86